DJIA 17,083.80 -2.83 -0.02%
NASDAQ 4,472.11 0.00 0.00%
S&P 500 1,987.98 0.97 0.05%
market minute promo

2.16 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTX $2.16 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $2.16
Daily Range $0.00 - $0.00
52-Week Range $2.00 - $3.93
Market Cap $163.0M
P/E Ratio -5.14
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 365,115
Current FY EPS -$0.37

Sector

Healthcare

Industry

Drugs

Cytori Therapeutics, Inc. (USA) (CYTX) Description

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. Website: http://www.cytori.com/

News & Commentary

Fast and Furious Health Care Stocks This Week

MannKind, Cytori Therapeutics, and Omeros are among the health care stocks soaring this week.

2 Small Cap Biotechs Insiders And Analysts Are Positive On

Morning Market Movers

Sector Update: Healthcare Shares Flat Pre-Market; Cytori Down 1% on Plans to Sell 4 Mln Units

Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2014 Results - Earnings Call Transcript

Cytori Therapeutics Announces Date For Crucial BARDA Meeting

Cytori Announces Senior Management Changes; Christopher Calhoun CEO and Director of Cytori Therapeut

Cytori Announces Senior Management Changes; Christopher Calhoun CEO and Director of Cytori Therapeutics, is Retiring as CEO of the Company, Effective Immediately

4 Stocks Under $10 Triggering Breakouts

Cytori Therapeutics: Global Patient Stem Cell Demand Builds, Important Short-Term Catalysts Ahead

Cytori Therapeutics Is A Cell Therapy Company With Several Positive Catalysts For 2014

A Glimpse At Our Small Cap Biotechnology Portfolio

See More CYTX News...

CYTX's Top Competitors

CYTX $2.16 (0.00%)
Current stock: CYTX
AMGN $122.26 (0.00%)
Current stock: AMGN
GILD $90.54 (0.00%)
Current stock: GILD
BIIB $336.79 (0.00%)
Current stock: BIIB